BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29579692)

  • 21. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
    Kato M; Okada K
    Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific antigen and new related markers for prostate cancer.
    Daher R; Beaini M
    Clin Chem Lab Med; 1998 Sep; 36(9):671-81. PubMed ID: 9804390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer.
    Haroun AA; Hadidy AS; Awwad ZM; Nimri CF; Mahafza WS; Tarawneh ES
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):291-7. PubMed ID: 21422628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
    Hernández J; Thompson IM
    Cancer; 2004 Sep; 101(5):894-904. PubMed ID: 15329895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic specific antigen. From its early days until becoming a prostate cancer biomarker.
    Dellavedova T
    Arch Esp Urol; 2016; 69(1):19-23. PubMed ID: 26856734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PSA and the family physician.
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():20-3. PubMed ID: 21501547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline prostate-specific antigen testing at a young age.
    Loeb S; Carter HB; Catalona WJ; Moul JW; Schroder FH
    Eur Urol; 2012 Jan; 61(1):1-7. PubMed ID: 21862205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
    J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer].
    Nutahara K; Higashihara E
    Rinsho Byori; 2001 Oct; 49(10):963-6. PubMed ID: 11769472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen and the early diagnosis of prostate cancer.
    Caplan A; Kratz A
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S104-8. PubMed ID: 14569806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass screening of 12,027 elderly men for prostate carcinoma by measuring serum prostate specific antigen.
    Zhang HF; Wang HL; Xu N; Li SW; Ji GY; Li XM; Pan YZ; Zhang L; Zhao XJ; Gao HW
    Chin Med J (Engl); 2004 Jan; 117(1):67-70. PubMed ID: 14733776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology consultation on prostate-specific antigen testing.
    Noguez JH; Fantz CR
    Am J Clin Pathol; 2014 Jul; 142(1):7-15. PubMed ID: 24926079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study.
    Wada Y; Nakanishi J; Takahashi W; Kai N; Nakayama Y; Yamashita Y; Honda J; Ueda S
    BJU Int; 2006 Oct; 98(4):794-7. PubMed ID: 16978274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.